Member Info for Newuncle

Well looks like the anchor holding these back has finally been released, can't wait to see the impact of further updates whether its more TR1s or business news from OBD, today is a good day.

Odey sold all?

Question now is are they investors or looking to perhaps manage a buy out potentially?

Looks like an acquisition vehicle set up by 5 big hitters to me

Gimme but 5 active officers and all big hitters in the financial world too

Ooh look what I found you can click on the connections, very interesting

https://www.marketscreener.com/business-leaders/Andrew-Salmon-06P7JB-E/biography/

Andrew Alfred SALMON

Jeremy Robin KAYE

James Robert COBB

Nicholas David De Burgh JENNINGS

Stephen John FLETCHER

Current officers......any names sound familiar?

The rns suggests they could have been at 2.9%+ on Thursday and then acquired a massive amount on Friday to go 9% but volumes that day don't support it unless shares bought off market from other players

Tricky can't see the volumes on charts to explain their tr1, how did it happen?

How have they got over 9% as of 3 Nov? Must have been some many millions taken by them off market but from who? If it is vulpe then they would have to rns their tr1 too . Really nice RNs just confused by it

Kaeren,

Hopefully OBD will mature a bit quicker than your average oak tree though....

Because they are slow-growing trees, it takes five or six years before the oak tree will be fully self-sustaining. Its growth slows down as it ages, and it will take several decades before it is fully grown.

Swing on tax exempt re inheritance tax after 2 years

On the whole, AIM shares are treated just the same as those on the Main Market, in that income generated through dividends is taxable, and gains are subject to Capital Gains Tax (CGT).

RNS out and there another reason to hold on tight to these golden tickets

Just got to hang tough and remember why you bought in here whilst the market plays

That article is not for obd test but does at least mentioned ai in determining cancer much more accurately without invasive testing, sound familiar?

Artificial intelligence is nearly twice as good at grading the aggressiveness of a rare form of cancer from scans as the current method, a study suggests.

By recognising details invisible to the naked eye, AI was 82% accurate, compared with 44% for lab analysis.

Researchers from the Royal Marsden Hospital and Institute of Cancer Research say it could improve treatment and benefit thousands every year.

Lambos for everyone

2 billion then davey

Lots of sells must be fake numbers, MMs dirty tricks

No placing required, plenty of cash in the bank (just not showing yet). Billion pound business this one.